Skip to main content
OpenTrials
Completed

NCT Number: NCT02325752

A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients

The investigators conducted an open randomized control study of patients who received the transitional care program versus patients who received usual care at the Singapore General Hospital from Aug 2011 to Sept 2012.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The investigators conducted an open randomized control study of patients who received the transitional care program versus patients who received usual care at the Singapore General Hospital from Aug 2011 to Sept 2012.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with 2 or more unscheduled admission in the last 90 days to selected medical departments
  • LACE score of ≥10.

Exclusion criteria

  • Non-residents
  • No telephone contact or a resident address
  • Residing in long term care facilities.

Treatment and study plan

Intervention

Other

A multidisciplinary team delivered the transitional care program.

Our transitional care program focused on four key areas:

  • Post discharge surveillance of the patient to ensure adherence to care plans.
  • Coordination of follow-up visits with specialist care providers.
  • Patent education and care giver training.
  • Activation of community and social services.

Upon recruitment, the patients were interviewed and assessed by the team nurse prior to their discharge. Intervention starts upon discharge from the hospital. The duration of the intervention program was 3 months. A follow-up by telephone was made within 72 hours after discharge to assess patient's condition and adherence to treatment plan. Home visits were made within 2 weeks after discharge.

Primary outcomes

  1. Rate of readmission

    Time frame: 30 days

    Any hospital admission after randomisation

Sponsors and collaborators

Lead sponsor

Singapore General Hospital

Other

Collaborators

  • Agency for Integrated Care, Singapore
  • Duke-NUS Graduate Medical School

Registry information

Important dates

Study start
2011
Primary completion
2012
Study completion
2013
First posted
Dec 25, 2014
Registry last updated
Feb 10, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.